临床进展 · III期简讯
Dovato在初治HIV成人头对头研究中疗效不逊于Biktarvy
【原文标题】ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
葛兰素史克公告发布于
【摘要】
ViiV Healthcare公告，在初治HIV成人的首次头对头研究中，Dovato双药方案的疗效不逊于Biktarvy三药方案。